Transport Validation Sample Protocol : Pharmaceutical Guidelines

Editable Pharmaceutical Documents in MS-Word Format

View

8

Transport Validation Sample Protocol

Pharmaceutical products may be damaged during the transportation. Sometimes temperature may harm the product because the rise in temperature during transportation. Validation protocol for transportation of pharmaceutical products.
1.0 OBJECTIVE
1.1 To evaluate the effect of transportation on the quality of (Product Name) packed in standard primary and other packaging systems. 
1.2 To evaluate the effect of transportation by air on the sterility of material filled into Aluminum containers supplied by M/S [Supplier Name].
2.0 ACCEPTANCE CRITERIA
2.1 The physical status [shape and integrity] of the primary and another packaging should not have any damage, on transportation.
2.2 The product should pass the tests listed below as per limits specified, after shipment from [Origin] to [Place 2] and back to [Origin].

Sample collected from the container before and after the transportation should pass the sterility test.
Test to be carried out and their limits are as below.

Tests
Limits
Description

Assay

Clarity of Solution

Loss on Drying

Related Substances

Total Impurities

pH

Sterility

Particle Size

Bulk Density


3.0 RESPONSIBILITIES
Validation group consists of the following members:
3.1 *****
3.2 *****
3.3 *****
4.0 VALIDATION TEST PROCEDURE
4.1 Methodology
4.1.1 Fill two batches of (Product Name) in Aluminium containers supplied by [Supplier Name] having 5 Kg sterile material to fill in each container.
4.1.2 Sample the material as per sampling SOP for sampling before transportation and for control purpose.
4.1.3 Transfer the container to the packing room.
4.1.4 Label the container.
4.1.5 Keep the container in Thermocol box.
4.1.6 Put the container in shipper box.
4.1.7 Paste label on shipper box.
4.1.8 After approval of QC, load 2 shipper boxes of each batch on the vehicle.
4.1.9 Send the material to [Place 1] by road in a lorry, normally utilized for transportation of the material.
4.1.10 [Place 1] depot will further send the boxes to [Place 2] and [Place 2] depot will send the container back to [Origin].
4.1.11 On receipt of shipper boxes at [Origin], inspect shipper boxes for any visible damage from outside.
4.1.12 Transfer the boxes to the decartoning room of vial filling plant.
4.1.13 Observe the containers for any physical damage.
4.1.14 Record the observations.
4.1.15 If no damage is observed to the containers, transfer the containers to the sterile area of vial filling plant for sampling by Microbiologist.
4.1.16 Withdraw about 30 g sample from each container for post transportation analysis.
4.1.17 Tabulate the data generated. Compare the data obtained before the transportation and after receiving the material back at [Origin].

4.2 Worst Case Situation
4.2.1 The lorry without any temperature control system will be used, hence the material will experience temperature between 22 to 35°C during transit.
4.2.2 In routine case the material for export is transported from [Origin] to [Place 1] by road and thereafter it is transported by Air. However, for this study, the material will be brought back to [Origin] via [Place 1] thus traveling more than double the distance by road. This situation provides the worst case for the physical properties of the material.
4.3 Microbiological Method
4.3.1 Soybean Casein Digest Medium will be prepared as per the SOP in the plant autoclave and sterilize for 30 minutes at 121° C.
4.3.2 After sterilization of the media the container will be sealed with aluminum seal.
4.3.3 After sterilization it will be transferred to the parking area.
4.3.4 Label the container.
4.3.5 The container having media will be packed with a polyethylene bag and then placed within the shipper box.
4.3.6 Keep the container in Thermocol box.
4.3.7 Put the container in shipper box.
4.3.8 Paste label on shipper box.
4.3.9 Send the material to [Place1] by road in a lorry, normally utilized for transportation of the material from [Origin]  to [Place 1] during export.
4.3.10 [Place 1] depot will further send the boxes to [Place 2] and [Place 2] depot will send the container back to [Origin].
4.3.11 On receipt of shipper boxes at [Origin], inspect shipper boxes for any visible damage from outside.
4.3.12 Bring the shipper box in the microbiology lab.
4.3.13 Place the container in the LAF in the controlled area.
4.3.14 Tilt the container slowly and sample 100 ml of the medium and check for the sterility of the medium.
4.3.15 Sample 100 ml of the medium for Growth Promotion Test if no growth is observed in the media
4.4 Worst Case Situation
4.4.1 Normally the product is filled aseptically into the containers and the containers are sealed and packed and are transported to the destination. In the present study, the containers containing sterile media were used, which had already traveled from [Origin] to [Place 2]  and back to [Origin] by road, after their receipt from road transportation, the containers were desealed for sampling.
5.0 EVALUATION OF RESULTS
5.1 Evaluations should be based on the basis of :
The comparison of the physical status of shipper box, label, seal and container before and after transportation itself will establish that packaging is satisfactory and no damage has occurred during transit.
5.2 The comparison of the analytical and microbiological data will establish the effect of transportation on the quality of the product.
5.3 On the basis of the results of the test for sterility, and physical observations it is concluded that the containers are suitable for transportation by air and the integrity of the containers (seal) is not affected at high altitudes, which may cause pressure differentials during transportation by air.

6.0 SCHEDULE REVALIDATION
Revalidation shall be carried out in case of a new vendor for the container is approved.
7.0 DOCUMENTATION:
Validation Report contains the following documents.
  • Approved Validation protocol
  • Test reports
  • Summary Conclusion
8.0 CONCLUSION
A summary report will contain discussion and conclusion, which clearly state the successful achievement of the objective of transport validation studies.
Get ready to use editable documents in MS-Word FormatView List





Ankur Choudhary is India's first professional pharmaceutical blogger, author and founder of Pharmaceutical Guidelines, a widely-read pharmaceutical blog since 2008. Sign-up for the free email updates for your daily dose of pharmaceutical tips.
.moc.enilediugamrahp@ofni :liamENeed Help: Ask Question


Click Here

No comments: Read Comment Policy ▼

Post a Comment


Popular Categories

QA SOPs QC SOPs Micro SOPs HVAC Production SOPs Stores SOPs Checklists Maintenance SOPs HPLC Sterile GLP Validation Protocols Water System GDP Regulatory Maintenance Calibration Warning Letters

Follow Pharmaguideline


DOCUMENTS

PHARMACEUTICAL DOCUMENTS




Editable Pharmaceutical Documents in MS-Word Format. Ready to use SOPs, Protocols, Master Plans, Manuals and more...

View


adsbypg

Discussion - Latest Topics

Show All ❭❭Pharmaguideline Forum



GET APP FOR NEWS UPDATES

Pharmaceutical Updates




✔ Worldwide Regulatory Updates
✔ Pharmaceutical News Updates
✔ Interview Questions and Answers
✔ All Guidelines in One Place

Install


Recent Posts